Global Genomics Market to Grow at 12.77% During 2025-2033, Strengthened by Extensive Government Investments in Research

January 13, 2025 | Healthcare

The latest report by IMARC Group, titled “Genomics Market Report by Component (Products, Services), Application (Functional Genomics, Epigenomics, Biomarkers Discovery, Pathway Analysis, and Others), Technology (Sequencing, Microarray, Polymerase Chain Reaction, Nucleic Acid Extraction and Purification, and Others), End-User (Research Centers, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2025-2033,” finds that the global genomics market reached a value of USD 38.4 Billion in 2024. Genomics is the study of the structure of the genome that contains non-coding DNA, genes, chloroplast, and mitochondrial DNA. It is employed to prevent, manage, and treat diseases. Genomics aims to understand the mapping of the genes and sequence the DNA by examining the molecular mechanisms and the interplay of genetic and environmental factors in diseases. Genomics is also instrumental in solving complex genetic problems, and the examination of the biological functions of individual genes is a common process in medical and biological research. As a result, genomics finds application in diagnostics, drug discovery, development of precision medicine, and agricultural research.


Global Genomics Market Trends: 

The market is primarily driven by the growing demand for personalized medicine to provide effective treatment. Genomics is also used in the agricultural sector to produce genetically modified (GM) plants and organisms. Besides this, the introduction of microarrays and DNA technologies backed by genomics is attracting extensive investment from government and private agencies. Along with this, governments of various countries are promoting research and development activities in the field of genomics, which, in turn, is providing a favorable market outlook. In addition to this, the rising incidences of chronic diseases and cancer have resulted in the growing adoption of non-invasive cancer screening-based research, thereby propelling the market growth. Moreover, the advent of next-generation sequencing technology has enabled the development of life-science databases and projects to support scientific research, which is propelling the market growth. Looking forward, the market value is projected to reach USD 113.3 Billion by 2033, expanding at a CAGR of 12.77% during 2025-2033.


Market Summary: 

  • Based on the component, the market has been segmented into products (instruments and software, and, consumables and reagents) and services (core genomics, NGS-based, biomarker translation, computational, and other services).
  • On the basis of the application, the market has been classified into functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others.
  • The market has been categorized based on the technology into sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others.
  • On the basis of the end-user, the market has been segregated into research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and others.
  • Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined, with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer AG, BGI Genomics Co. Limited, Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units  Billion USD
Segment Coverage Component, Application, Technology, End-User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Genomics Market to Grow at 12.77% During 2025-2033, Strengthened by Extensive Government Investments in Research
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials